Brief: Inhibikase Therapeutics To Present Phase 1/1B Clinical Data At The Upcoming Ad/Pd Alzheimer's & Parkinson's Diseases Conference
08/03/2022 13:29
March 8 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* INHIBIKASE THERAPEUTICS TO PRESENT PHASE 1/1B CLINICAL DATA AT THE
UPCOMING
AD/PD™ ALZHEIMER'S & PARKINSON'S DISEASES CONFERENCE
Source text for Eikon: ID:nPnbKRYwHa
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share